Q1 EPS Estimate for Eton Pharmaceuticals Raised by Analyst
Eton Pharmaceuticals, Inc. (NASDAQ:ETON – Free Report) – Investment analysts at B. Riley increased their Q1 2025 earnings estimates for shares of Eton Pharmaceuticals in a research note issued to investors on Wednesday, March 19th. B. Riley analyst M. El-Saadi now anticipates that the company will post earnings per share of $0.06 for the quarter, […]
